Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Assets (2020 - 2025)

Benitec Biopharma's Return on Assets history spans 4 years, with the latest figure at 0.9% for Q4 2023.

  • For Q4 2023, Return on Assets changed N/A year-over-year to 0.9%; the TTM value through Dec 2023 reached 0.9%, changed N/A, while the annual FY2024 figure was 0.76%, 290.0% up from the prior year.
  • Return on Assets for Q4 2023 was 0.9% at Benitec Biopharma, up from 1.29% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.78% in Q2 2021 and bottomed at 1.47% in Q3 2022.
  • The 4-year median for Return on Assets is 0.9% (2023), against an average of 1.02%.
  • The largest YoY upside for Return on Assets was 17bps in 2023 against a maximum downside of 17bps in 2023.
  • A 4-year view of Return on Assets shows it stood at 0.89% in 2020, then grew by 13bps to 0.78% in 2021, then tumbled by -88bps to 1.47% in 2022, then surged by 39bps to 0.9% in 2023.
  • Per Business Quant, the three most recent readings for BNTC's Return on Assets are 0.9% (Q4 2023), 1.29% (Q3 2023), and 1.47% (Q3 2022).